We demonstrate that c-mycgene expression is essential for growth of breast cancer cells. It also plays an important role in the progression of human breast cancer. c-myc gene amplification may be important for cancer cell invasion, but perhaps not essential for nodal metastasis. We also provide compelling evidence that the c-myconcogene is an estrogen target gene in hormone-responsive breast cancer. Hormonal progression of breast cancer could be brought about by the enhanced expression of the c-mycgene, with gene amplificationand enhanced c-myc mRNA stability being two major mechanisms involved. 
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Tumor progression encompasses multiple changes in-

c-myc Expressionand the Effectsof Estrogen
We next studied the role of c-myc oncogene expression in the estrogen-induced growth of breast cancer and in the progression of breast cancer from a hormone-dependent to a hormone-independent, autonomous state. cells. Neither the c-myc-specific sense oligonucleotide nor the pS2-specific antisense oligonucleotide affected the growth of these cell lines. These results lend further support to the notion that c-myc expression alone is sufficient to provide the necessary growth stimulus to both hormone-responsive and nonresponsive breast cancer cells. Because the growth of the MCF-7 cells was not impeded, despite the >80% blockade of p82 synthesis by the pS2-specific antisense oligonucleotide, we conclude that pS2 is not essential for growth of breast cancer.
